Neurogastrx's Series A Round

Neurogastrx raised a round of funding on January 04, 2018.

Neurogastrx is a private biopharmaceutical company focused on developing therapies for gastrointestinal disorders affecting the enteric nervous system.…

Articles about Neurogastrx's Series A Round: